These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 31435725)

  • 21. Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.
    Dorresteijn EM; Kist-van Holthe JE; Levtchenko EN; Nauta J; Hop WC; van der Heijden AJ
    Pediatr Nephrol; 2008 Nov; 23(11):2013-20. PubMed ID: 18622632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I; Szczęsny-Choruz E; Wierzchowska-Słowiaczek E; Kwinta-Rybicka J; Stec Z; Moczulska A; Wilkosz K; Drożdż D
    Pol Merkur Lekarski; 2018 Apr; 44(262):192-195. PubMed ID: 29775447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
    Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is The Best Choice in Steroid-Dependent Nephrotic Syndrome: Mycophenolate Mofetil Plus Dexamethasone or Cyclosporine A.
    Tunçay SC; Mir S; Hakverdi G
    Saudi J Kidney Dis Transpl; 2021; 32(4):1019-1027. PubMed ID: 35229801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
    Barletta GM; Smoyer WE; Bunchman TE; Flynn JT; Kershaw DB
    Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus can induce remission in cyclosporine and mycophenolate mofetil resistant pediatric onset nephrotic syndrome.
    Ahmed HM
    Iran J Kidney Dis; 2019 Sep; 13(5):322-327. PubMed ID: 31705749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
    Ulinski T; Dubourg L; Saïd MH; Parchoux B; Ranchin B; Cochat P
    Pediatr Nephrol; 2005 Apr; 20(4):482-5. PubMed ID: 15719253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
    Sharma S; Kalra S; Shukla S; Sharma P
    Nephrology (Carlton); 2022 Sep; 27(9):758-762. PubMed ID: 35619554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study.
    Katsuno T; Masuda T; Saito S; Kato N; Ishimoto T; Kato S; Kosugi T; Tsuboi N; Kitamura H; Tsuzuki T; Ito Y; Maruyama S
    Clin Exp Nephrol; 2019 Feb; 23(2):207-214. PubMed ID: 30121802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T
    Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
    Ohtomo Y; Fujinaga S; Takada M; Murakami H; Akashi S; Shimizu T; Kaneko K; Yamashiro Y
    Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.
    Vivarelli M; Colucci M; Bonanni A; Verzani M; Serafinelli J; Emma F; Ghiggeri G
    Pediatr Nephrol; 2017 Jan; 32(1):181-184. PubMed ID: 27687621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.
    Kamei K; Ishikura K; Sako M; Aya K; Tanaka R; Nozu K; Kaito H; Nakanishi K; Ohtomo Y; Miura K; Takahashi S; Morimoto T; Kubota W; Ito S; Nakamura H; Iijima K;
    Pediatr Nephrol; 2017 Nov; 32(11):2071-2078. PubMed ID: 28664242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome.
    Gellermann J; Weber L; Pape L; Tönshoff B; Hoyer P; Querfeld U;
    J Am Soc Nephrol; 2013 Oct; 24(10):1689-97. PubMed ID: 23813218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
    Kemper MJ; Kuwertz-Broeking E; Bulla M; Mueller-Wiefel DE; Neuhaus TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1136-41. PubMed ID: 14993510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome.
    Gargah TT; Lakhoua MR
    J Nephrol; 2011; 24(2):203-7. PubMed ID: 21319130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial.
    Baudouin V; Alberti C; Lapeyraque AL; Bensman A; André JL; Broux F; Cailliez M; Decramer S; Niaudet P; Deschênes G; Jacqz-Aigrain E; Loirat C
    Pediatr Nephrol; 2012 Mar; 27(3):389-96. PubMed ID: 21947272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.
    Fujinaga S; Hirano D; Nishizaki N; Kamei K; Ito S; Ohtomo Y; Shimizu T; Kaneko K
    Pediatr Nephrol; 2010 Mar; 25(3):539-44. PubMed ID: 20049616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
    Aizawa-Yashiro T; Tsuruga K; Watanabe S; Oki E; Ito E; Tanaka H
    Pediatr Nephrol; 2011 Aug; 26(8):1255-61. PubMed ID: 21479767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.